Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00925470 |
Date of registration:
|
19/06/2009 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure
PREVENTA |
Scientific title:
|
Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure Without Known Cardio Vascular or Renal Disease, Stratified on Blood Pressure Control. |
Date of first enrolment:
|
June 2009 |
Target sample size:
|
1200 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00925470 |
Study type:
|
Observational |
Study design:
|
Observational Model: Cohort, Time Perspective: Cross-Sectional
|
Phase:
|
N/A
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
Alain Castaigne, Medical Director |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
AstraZeneca |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Adults with hypertension (treated or not), without known cardiovascular or renal
disease.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Blood Pressure
|
Primary Outcome(s)
|
To evaluate the frequency of evaluation of target organs preclinical impairment on patients without known cardiovascular or renal disease, taking into consideration the blood pressure level (controlled HBP or not)
[Time Frame: Once]
|
Secondary ID(s)
|
NIS-CFR-DUM-2009/1
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|